Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation

Institut Paoli-Calmettes1 site in 1 country235 target enrollmentSeptember 27, 2013

ConditionsBreast Neoplasms

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast Neoplasms
Sponsor: Institut Paoli-Calmettes
Enrollment: 235
Locations: 1
Primary Endpoint: Overall Survival according to Immunohistochemical subtypes .
Status: Completed
Last Updated: 8 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study was to evaluate the outcome of patients affected with different subtypes of metastatic breast cancer following treatment with high-dose chemotherapy and autologous haematopoietic progenitor cell transplantation.

Registry

clinicaltrials.gov

Start Date

September 27, 2013

End Date

February 29, 2016

Last Updated

8 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Institut Paoli-Calmettes

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age\>18 years
•Metastatic breast Cancer
•Treatment with high-dose chemotherapy and autologous haematopoietic progenitor cell transplantation between 2003 and 2012